SCHEMBL25926569

SCHEMBL25926569

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3cccc(-c5cccc6oc7cc(-n8c9ccccc9c9ccccc98)ccc7c56)c34)n2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 1/20 0.35
KDM4E B2RXH2 4/20 0.35
ATM Q13315 3/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
ALDH1A1 P00352 4/20 0.33
MAPT P10636 4/20 0.33
HPGD P15428 4/20 0.33
TSHR P16473 2/20 0.33
TP53 P04637 2/20 0.33
MAPK1 P28482 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
BACE1 P56817 1/20 0.31
DUSP3 P51452 1/20 0.31
MEN1 O00255 3/20 0.31
KMT2A Q03164 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25720239 0.96 PTGER4 (0.36) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL25926550 0.96 PTGER4 (0.36) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL21671435 0.95 PTGER4 (0.35) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL25926699 0.95 PTGER4 (0.35) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL25926570 0.95 PTGER4 (0.33) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL24216340 0.95 PTGER4 (0.38) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL24232707 0.95 PTGER4 (0.35) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL25926792 0.95 PTGER4 (0.33) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL24216215 0.95 PTGER4 (0.38) PTGER4KDM4EATML3MBTL1ALDH1A1
SCHEMBL21667149 0.94 PTGER4 (0.34) PTGER4KDM4EATML3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE CRY1, PPOX, ORC3 PTGER4 2825/4885KDM4E 2352/4885ATM 2148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.